查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
蛋白质晶片的全球市场 - 产业分析，规模，占有率，成长，趋势，预测(2023年～2030年):各产品，各技术，各等级，各用途，各终端用户，各地区
市场调查报告书
商品编码
1318090

蛋白质晶片的全球市场 - 产业分析，规模，占有率，成长，趋势，预测(2023年～2030年):各产品，各技术，各等级，各用途，各终端用户，各地区

Protein Chip Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 220 Pages | 商品交期: 2-5个工作天内

价格
简介目录

由于慢性病的流行和对先进治疗方案的需求不断增加，全球蛋白质芯片市场呈现快速增长。医疗行业的发展以及对改进疾病监测和临床诊断的需求不断增长，对市场增长产生了重大影响。蛋白质微阵列方法可以在一次实验中进行广泛的分析，已成为一个独特的卖点，并有助于市场扩张。根据费尔菲尔德市场研究公司的初步研究，全球癌症的高患病率预计将支持市场增长。

蛋白质芯片市场受益于 COVID-19 爆发和癌症流行

COVID-19 的爆发凸显了诊断在控制疫情方面的重要性，导致对功能分析方法的需求激增。因此，研究人员专注于通过各种检测来识别蛋白质-病毒相互作用，使功能分析成为一个利润丰厚的增长领域。

另一方面，癌症仍然是全世界预期寿命缩短的主要原因。据世界卫生组织(WHO)称，到2020年，将有超过1900万新发癌症病例和约1000万癌症相关死亡。蛋白质芯片在高效癌症诊断中的关键作用是通过并行跟?各种蛋白质相互作用、靶标、小分子、蛋白激?底物和蛋白质-磷脂相互作用，实现快速、轻鬆的诊断，并推动市场需求。蛋白质芯片在分子生物学和生物化学领域的广泛应用，以及个性化医疗领域的不断增长，进一步增强了其在医疗行业的重要性。

蛋白质组学成为蛋白质芯片的主要应用

蛋白质组学是 2019 年蛋白质芯片的领先应用领域，预计未来几年将保持这一地位。其在生物医学研究和药物发现中的广泛应用预计将成为市场的主要收入来源。蛋白质组学应用于多种技术，包括表面流体色谱、层析、X射线晶体学、蛋白质分级分离、光谱学、表面等离子体共振和电泳。准确分析体内结果的能力使其成为研究肿瘤耐药机制、疾病病因和治疗开发的重要工具。

北美和欧洲引领全球蛋白质芯片市场

预计2021-2026年北美将保持其在全球蛋白质芯片市场的主导地位。该地区领先的生物技术公司预计将大力投资于创新技术的研发。随着癌症和 COVID-19 患病率上升，欧洲也有望出现积极增长，需要立即采取行动。亚太地区也将效仿，分析师预测采用蛋白质芯片进行诊断将为该地区带来利润丰厚的机会。

本报告提供全球蛋白质晶片市场相关调查分析，提供市场动态，各地区预测，企业简介等资讯。

目录

第1章 摘要整理

  • 全球蛋白质晶片市场预测(2018年～2030年)
  • 全球蛋白质晶片市场成长机会(2018年～2030年)
  • 主要的产业趋势

第2章 市场概要

  • 市场定义和市场区隔
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 市场机会矩阵
  • 波特的五力分析
  • 法规指南偿付情势
  • COVID-19影响的分析

第3章 价格分析(2021年)

  • 平均销售价格:主要各地区

第4章 全球蛋白质晶片市场预测(2018年～2030年)

  • 全球蛋白质晶片市场预测:各技术(金额)(2018年～2030年)

第5章 全球蛋白质晶片市场预测(2018年～2030年)

  • 全球蛋白质晶片市场预测:各用途(金额)(2018年～2030年)
  • 全球蛋白质晶片市场预测:各终端用户(金额)(2018年～2030年)
  • 全球蛋白质晶片市场预测:各地区(金额)(2018年～2030年)

第6章 北美的蛋白质晶片市场预测(2018年～2030年)

  • 北美的蛋白质晶片市场预测:各技术(金额)(2018年～2030年)
  • 北美的蛋白质晶片市场预测:各用途(金额)(2018年～2030年)
  • 北美的蛋白质晶片市场预测:各终端用户(金额)(2018年～2030年)
  • 北美的蛋白质晶片市场预测:各国(金额)(2018年～2030年)

第7章 欧洲的蛋白质晶片市场预测(2018年～2030年)

  • 欧洲的蛋白质晶片市场预测:各技术(金额)(2018年～2030年)
  • 欧洲的蛋白质晶片市场预测:各用途(金额)(2018年～2030年)
  • 欧洲的蛋白质晶片市场预测:各终端用户(金额)(2018年～2030年)
  • 欧洲的蛋白质晶片市场预测:各国(金额)(2018年～2030年)

第8章 亚太地区的蛋白质晶片市场预测(2018年～2030年)

  • 亚太地区的蛋白质晶片市场预测:各技术(金额)(2018年～2030年)
  • 亚太地区的蛋白质晶片市场预测:各用途(金额)(2018年～2030年)
  • 亚太地区的蛋白质晶片市场预测:各终端用户(金额)(2018年～2030年)
  • 亚太地区的蛋白质晶片市场预测:各国(金额)(2018年～2030年)

第9章 其他地区的蛋白质晶片市场预测(2018年～2030年)

  • 其他地区的蛋白质晶片市场预测:各技术(金额)(2018年～2030年)
  • 其他地区的蛋白质晶片市场预测:各用途(金额)(2018年～2030年)
  • 其他地区的蛋白质晶片市场预测:各终端用户(金额)(2018年～2030年)
  • 其他地区的蛋白质晶片市场预测:各国(金额)(2018年～2030年)

第10章 竞争情形

  • 企业的市场占有率分析
  • 企业简介
    • ArrayIt Corporation
    • PerkinElmer, Inc.
    • Thermo Fischer Scientific
    • Lumicyte
    • Bio-Rad Laboratories
    • Illumina, Inc.
    • Ciphergen Biosystems
    • Agilent Technologies
    • 其他

第11章 附录

简介目录

The global protein chip market is experiencing rapid growth, driven by the increasing prevalence of chronic diseases and the demand for advanced treatment options. The evolution of the healthcare sector has been a major influencer for the market's growth, with a growing need for improved disease monitoring and clinical diagnostics. The protein microarray method, which allows for a wide range of analyses in a single experiment, has become a unique selling point, contributing to the market's expansion. Fairfield Market Research's preliminary findings indicate that the high prevalence of cancer worldwide is expected to underpin the growth of the protein chip market.

Protein Chip Market Benefitting from COVID-19 Outbreak and Cancer Prevalence

The outbreak of COVID-19 has highlighted the importance of diagnostics in containing the pandemic, leading to a surge in demand for functional analysis methods. This has made functional analysis a lucrative area of growth as researchers focus on identifying protein-virus interactions through various testing methods.

Cancer, on the other hand, remains a key cause of shortened life expectancy globally. According to the World Health Organization (WHO), there were over 19 million new cancer cases and approximately 10 million cancer-related deaths in 2020. The critical role of protein chips in efficient cancer diagnosis, allowing fast and easy diagnostics with parallel tracking of various protein interactions, targets, small molecules, substrates of protein kinases, and protein-phospholipid interactions, will drive market demand. The broad application scope of protein chips in molecular biology and biochemistry, along with the growing sector of personalized medicine, further enhances their significance in the healthcare industry.

Proteomics Emerges as the Leading Application for Protein Chips

As of 2019, proteomics stood as the leading application area for protein chips, and it is expected to maintain this position in the coming years. Its wide usage in biomedical research and drug discovery is anticipated to be a major revenue generator for the market. Proteomics is deployed in various techniques, including superficial fluid chromatography, chromatography, x-ray crystallography, protein fractionation, spectroscopy, surface plasmon resonance, and electrophoresis. Its ability to offer accurate analysis of in-vivo outcomes makes it an essential tool in the study of tumour resistance mechanisms, disease pathogenesis, and therapeutic developments.

North America and Europe to Lead the Global Protein Chip Market

North America is expected to maintain its dominance in the global protein chip market from 2021 to 2026. Well-established biotech companies in the region are projected to invest significantly in research and development of innovative technologies. Europe is also expected to show positive growth due to the rising incidence of cancer and COVID-19, prompting swift action. Analysts anticipate that Asia Pacific will closely follow this development, with protein chip adoption for diagnostics presenting lucrative opportunities in the region.

Key Players in the Global Protein Chip Market

The competitive landscape of the global protein chip market is shaped by leading players such as Sigma Aldrich Corporation, Affymetrix, Inc., Biacore, SEQUENOM, Inc., Illumina, Inc., Agilent Technologies, HTS Biosystems, EMD Millipore, Life Technologies Corporation, Lumicyte, and Ciphergen Biosystems.

Table of Contents

1. Executive Summary

  • 1.1. Global Protein Chip Market Outlook, 2018 - 2030 (US$ Million)
  • 1.2. Global Protein Chip Market Incremental Opportunity, 2018 - 2030 (US$ Million)
  • 1.3. Key Industry Trends

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
      • 2.2.1.1. Driver 1
      • 2.2.1.2. Driver 2
    • 2.2.2. Restraints
      • 2.2.2.1. Restraint 1
      • 2.2.2.2. Restraint 2
    • 2.2.3. Market Opportunities Matrix
  • 2.3. Porters Five Forces Analysis
  • 2.4. Regulatory Guidelines & Reimbursement Scenario
  • 2.5. Covid-19 Impact Analysis

3. Pricing Analysis, 2021

  • 3.1. Average Selling Price, by Key Regions

4. Global Protein Chip Market Outlook, 2018 - 2030

  • 4.1. Global Protein Chip Market Outlook, by Technology, Value (US$ Mn), 2018 - 2030
    • 4.1.1. Key Highlights
      • 4.1.1.1. Functional
      • 4.1.1.2. Analytical
      • 4.1.1.3. Reverse Phase
      • 4.1.1.4. Others
    • 4.1.2. BPS Analysis/Market Attractiveness Analysis

5. Global Protein Chip Market Outlook, 2018 - 2030

  • 5.1. Global Protein Chip Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 5.1.1. Key Highlights
      • 5.1.1.1. Diagnostics
      • 5.1.1.2. Proteomics
      • 5.1.1.3. Drug Discovery
      • 5.1.1.4. Biomarker Research
      • 5.1.1.5. Others
    • 5.1.2. BPS Analysis/Market Attractiveness Analysis
  • 5.2. Global Protein Chip Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 5.2.1. Key Highlights
      • 5.2.1.1. Pharmaceutical & Biotech Companies
      • 5.2.1.2. Hospitals & Clinics
      • 5.2.1.3. Diagnostic Laboratories
      • 5.2.1.4. Research Institutes
      • 5.2.1.5. Others
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. Global Protein Chip Market Outlook, by Region, Value (US$ Mn), 2018 - 2030
    • 5.3.1. Key Highlights
      • 5.3.1.1. North America
      • 5.3.1.2. Europe
      • 5.3.1.3. Asia Pacific
      • 5.3.1.4. Rest of the World
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. North America Protein Chip Market Outlook, 2018 - 2030

  • 6.1. North America Protein Chip Market Outlook, by Technology, Value (US$ Mn), 2018 - 2030
    • 6.1.1. Key Highlights
      • 6.1.1.1. Functional
      • 6.1.1.2. Analytical
      • 6.1.1.3. Reverse Phase
      • 6.1.1.4. Others
    • 6.1.2. BPS Analysis/Market Attractiveness Analysis
  • 6.2. North America Protein Chip Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 6.2.1. Key Highlights
      • 6.2.1.1. Diagnostics
      • 6.2.1.2. Proteomics
      • 6.2.1.3. Drug Discovery
      • 6.2.1.4. Biomarker Research
      • 6.2.1.5. Others
    • 6.2.2. BPS Analysis/Market Attractiveness Analysis
  • 6.3. North America Protein Chip Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 6.3.1. Key Highlights
      • 6.3.1.1. Pharmaceutical & Biotech Companies
      • 6.3.1.2. Hospitals & Clinics
      • 6.3.1.3. Diagnostic Laboratories
      • 6.3.1.4. Research Institutes
      • 6.3.1.5. Others
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. North America Protein Chip Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 6.4.1. Key Highlights
      • 6.4.1.1. U.S.
      • 6.4.1.2. Canada
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Protein Chip Market Outlook, 2018 - 2030

  • 7.1. Europe Protein Chip Market Outlook, by Technology, Value (US$ Mn), 2018 - 2030
    • 7.1.1. Key Highlights
      • 7.1.1.1. Functional
      • 7.1.1.2. Analytical
      • 7.1.1.3. Reverse Phase
      • 7.1.1.4. Others
    • 7.1.2. BPS Analysis/Market Attractiveness Analysis
  • 7.2. Europe Protein Chip Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 7.2.1. Key Highlights
      • 7.2.1.1. Diagnostics
      • 7.2.1.2. Proteomics
      • 7.2.1.3. Drug Discovery
      • 7.2.1.4. Biomarker Research
      • 7.2.1.5. Others
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Europe Protein Chip Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 7.3.1. Key Highlights
      • 7.3.1.1. Pharmaceutical & Biotech Companies
      • 7.3.1.2. Hospitals & Clinics
      • 7.3.1.3. Diagnostic Laboratories
      • 7.3.1.4. Research Institutes
      • 7.3.1.5. Others
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Europe Protein Chip Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 7.4.1. Key Highlights
      • 7.4.1.1. Germany
      • 7.4.1.2. France
      • 7.4.1.3. U.K.
      • 7.4.1.4. Italy
      • 7.4.1.5. Spain
      • 7.4.1.6. Rest of Europe
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Protein Chip Market Outlook, 2018 - 2030

  • 8.1. Asia Pacific Protein Chip Market Outlook, by Technology, Value (US$ Mn), 2018 - 2030
    • 8.1.1. Key Highlights
      • 8.1.1.1. Functional
      • 8.1.1.2. Analytical
      • 8.1.1.3. Reverse Phase
      • 8.1.1.4. Others
    • 8.1.2. BPS Analysis/Market Attractiveness Analysis
  • 8.2. Asia Pacific Protein Chip Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 8.2.1. Key Highlights
      • 8.2.1.1. Diagnostics
      • 8.2.1.2. Proteomics
      • 8.2.1.3. Drug Discovery
      • 8.2.1.4. Biomarker Research
      • 8.2.1.5. Others
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Asia Pacific Protein Chip Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 8.3.1. Key Highlights
      • 8.3.1.1. Pharmaceutical & Biotech Companies
      • 8.3.1.2. Hospitals & Clinics
      • 8.3.1.3. Diagnostic Laboratories
      • 8.3.1.4. Research Institutes
      • 8.3.1.5. Others
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Asia Pacific Protein Chip Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 8.4.1. Key Highlights
      • 8.4.1.1. China
      • 8.4.1.2. Japan
      • 8.4.1.3. India
      • 8.4.1.4. South Korea
      • 8.4.1.5. Australia & New Zealand
      • 8.4.1.6. Rest of Asia Pacific
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Rest of the World Protein Chip Market Outlook, 2018 - 2030

  • 9.1. Rest of the World Protein Chip Market Outlook, by Technology, Value (US$ Mn), 2018 - 2030
    • 9.1.1. Key Highlights
      • 9.1.1.1. Functional
      • 9.1.1.2. Analytical
      • 9.1.1.3. Reverse Phase
      • 9.1.1.4. Others
    • 9.1.2. BPS Analysis/Market Attractiveness Analysis
  • 9.2. Rest of the World Protein Chip Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 9.2.1. Key Highlights
      • 9.2.1.1. Diagnostics
      • 9.2.1.2. Proteomics
      • 9.2.1.3. Drug Discovery
      • 9.2.1.4. Biomarker Research
      • 9.2.1.5. Others
    • 9.2.2. BPS Analysis/Market Attractiveness Analysis
  • 9.3. Rest of the World Protein Chip Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 9.3.1. Key Highlights
      • 9.3.1.1. Pharmaceutical & Biotech Companies
      • 9.3.1.2. Hospitals & Clinics
      • 9.3.1.3. Diagnostic Laboratories
      • 9.3.1.4. Research Institutes
      • 9.3.1.5. Others
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis
  • 9.4. Rest of the World Protein Chip Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 9.4.1. Key Highlights
      • 9.4.1.1. Latin America
      • 9.4.1.2. Middle East & Africa
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

  • 10.1. Company Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1. ArrayIt Corporation
      • 10.2.1.1. Company Overview
      • 10.2.1.2. Financial Overview
      • 10.2.1.3. Technology Portfolio
      • 10.2.1.4. Recent Developments
    • 10.2.2. PerkinElmer, Inc.
    • 10.2.3. Thermo Fischer Scientific
    • 10.2.4. Lumicyte
    • 10.2.5. Bio-Rad Laboratories
    • 10.2.6. Illumina, Inc.
    • 10.2.7. Ciphergen Biosystems
    • 10.2.8. Agilent Technologies
    • 10.2.9. Others

11. Appendix

  • 11.1. Research Methodology
  • 11.2. Report Assumptions
  • 11.3. Acronyms and Abbreviations